The NSS Research Grants Programme funds high-quality research aligned with our strategic priorities. Since 2020, we have awarded over €4.2 million across 35 projects in 22 countries.
2026 Grant Programme
Applications for the 2026 cycle open June 1, 2026 and close September 30, 2026. Awards will be announced in January 2027.
Innovation Grant
For novel diagnostic tools, therapeutic approaches, or technology solutions addressing neonatal sepsis. Supports proof-of-concept and early-stage validation studies.
Clinical Research Grant
For multicentre clinical studies, randomised trials, and large cohort studies addressing key questions in neonatal sepsis management, antimicrobial stewardship, and prevention.
Global Health Equity Grant
Dedicated to research improving sepsis outcomes in low- and middle-income countries. Supports implementation science, capacity building, and adapted interventions for resource-limited settings.
Early-Career Investigator Award
For investigators within 5 years of completing training. Seed funding to establish an independent research programme in neonatal infection. Includes mentorship from a senior NSS investigator.
Eligibility & Process
Key requirement: The principal investigator must be a current NSS member in good standing at the time of application and throughout the grant period.
Applications Open
Submit via the online portal with a 5-page research proposal, budget, CV, and institutional endorsement.
Applications Close
Deadline for all submissions. Late applications are not accepted.
Peer Review
Independent review by the NSS Research Committee with external expert reviewers. Applicants may be invited for interview.
Awards Announced
Successful applicants notified. Funding commences upon institutional agreement execution.